AU7638894A - B70(b7-2):ctla-4 bonding protein - Google Patents

B70(b7-2):ctla-4 bonding protein

Info

Publication number
AU7638894A
AU7638894A AU76388/94A AU7638894A AU7638894A AU 7638894 A AU7638894 A AU 7638894A AU 76388/94 A AU76388/94 A AU 76388/94A AU 7638894 A AU7638894 A AU 7638894A AU 7638894 A AU7638894 A AU 7638894A
Authority
AU
Australia
Prior art keywords
ctla
bonding protein
protein
bonding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76388/94A
Inventor
Miyuki Azuma
Lewis L. Lanier
Ko Okumura
Joseph H. Phillips
M. Chamorro Somoza Diaz-Sarmiento
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU7638894A publication Critical patent/AU7638894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU76388/94A 1993-09-03 1994-09-02 B70(b7-2):ctla-4 bonding protein Abandoned AU7638894A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11688293A 1993-09-03 1993-09-03
US116882 1993-09-03
US12060693A 1993-09-13 1993-09-13
US120606 1993-09-13
PCT/US1994/009642 WO1995006738A1 (en) 1993-09-03 1994-09-02 B70(b7-2):ctla-4 bonding protein

Publications (1)

Publication Number Publication Date
AU7638894A true AU7638894A (en) 1995-03-22

Family

ID=26814719

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76388/94A Abandoned AU7638894A (en) 1993-09-03 1994-09-02 B70(b7-2):ctla-4 bonding protein

Country Status (2)

Country Link
AU (1) AU7638894A (en)
WO (1) WO1995006738A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
US6084067A (en) 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US6218510B1 (en) 1994-03-02 2001-04-17 Brigham & Woman's Hospital B7-1 and B7-2 polypeptides
US6319906B1 (en) 1996-12-31 2001-11-20 Isis Pharmaceuticals Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US7235653B2 (en) 1996-12-31 2007-06-26 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
US6077833A (en) * 1996-12-31 2000-06-20 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
AU6703198A (en) * 1997-03-21 1998-10-20 Brigham And Women's Hospital Immunotherapeutic ctla-4 binding peptides
AU3107699A (en) 1998-03-19 1999-10-11 Heska Corporation Novel forms of t cell costimulatory proteins, nucleic acid molecules, and uses thereof
UA77382C2 (en) * 1998-05-01 2006-12-15 Shering Plough Ltd Isolated nucleic acid, which codes ligand cd86 of cat, diagnostic oligonucleotide, cloning vector, vaccine for modulation of immune response by cat and methods for induction or inhibition of immunity by cat
US7078512B2 (en) 1998-05-01 2006-07-18 Schering-Plough Animal Health Corporation Nucleic acid encoding feline CD86
DE19905501B4 (en) 1999-02-10 2005-05-19 MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie A method of producing a recombinant adeno-associated virus, suitable compositions therefor, and use for the manufacture of a medicament
US7011833B1 (en) 1999-05-06 2006-03-14 Genetics Institute, Inc. Enhancing immune responses with B7-1 or B7-2 in the absence of a crosslinking agent
US7960355B2 (en) 2003-05-23 2011-06-14 Isis Pharmaceuticals, Inc. Compositions and methods for the modulation of the expression of B7 protein
US7897582B2 (en) 2003-05-23 2011-03-01 Isis Pharmaceuticals, Inc. Oligonucleotide compositions and methods for the modulation of the expression of B7 protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0575537A1 (en) * 1991-03-08 1993-12-29 Cytomed, Inc. Soluble cd28 proteins and methods of treatment therewith
CA2580812A1 (en) * 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Ctla4 receptor, fusion proteins containing it and uses thereof

Also Published As

Publication number Publication date
WO1995006738A1 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU9482098A (en) Fusion protein systems
AU7489896A (en) Feed enzyme preparations
AU6255096A (en) Pegylated modified proteins
AU7203496A (en) Novel peptides
EP0750835A3 (en) Hedge shear
AU5446996A (en) Nitrosylated neuropeptides
AU1847497A (en) Protein expression system
AU7638894A (en) B70(b7-2):ctla-4 bonding protein
EP0621130A3 (en) Solid phase bonding method
AU6873596A (en) Allergen-xcd32 fusion proteins
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU7502994A (en) Fibre bonding
AU9798398A (en) Gfp-annexin fusion proteins
AU5412996A (en) Truncated igf-i
AU7583396A (en) Adhesives
AU7306394A (en) Booster
AU1373395A (en) Vpr receptor protein
AU7520396A (en) Abl-interactor protein
PL319157A1 (en) Pka bonding novel proteins an dtheir application
AU5284296A (en) Immune-evading proteins
AU4542096A (en) Connecting element
AU4942396A (en) Connecting component
AU7423796A (en) Novel stress proteins